Research Output 2003 2017

Filter
Article
2017

Adverse impact of high donor CD3+ cell dose on outcome following tandem auto-NMA allogeneic transplantation for high-risk myeloma

Nair, A. P., Walker, P., Kalff, A., Bergin, K., Hocking, J., Avery, S., Curtis, D. J., Patil, S., Das, T., Klarica, D., Morgan, S., Muirhead, J., Gorniak, M. B., Reynolds, J. & Spencer, A. 1 Jun 2017 In : Bone Marrow Transplantation. 52, 6, p. 839-845 7 p.

Research output: Contribution to journalArticle

Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: A pooled analysis

Gay, F. , Oliva, S. , Petrucci, M. T. , Montefusco, V. , Conticello, C. , Musto, P. , Catalano, L. , Evangelista, A. , Spada, S. , Campbell, P. , Ria, R. , Salvini, M. , Offidani, M. , Carella, A-M. , Omedé, P. , Liberati, A. M. , Troia, R. , Cafro, A. M. , Malfitano, A. , Falcone, A. P. & 7 others Caravita, T., Patriarca, F., Nagler, A., Spencer, A., Hajek, A. R., Palumbo, A. & Boccadoro, M. 1 Aug 2017 In : Leukemia. 31, 8, p. 1727-1734 8 p.

Research output: Contribution to journalArticle

BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1

Hogg, S. J., Vervoort, S. J., Deswal, S., Ott, C. J., Li, J., Cluse, L. A., Beavis, P. A., Darcy, P. K., Martin, B. P., Spencer, A., Traunbauer, A. K., Sadovnik, I., Bauer, K., Valent, P., Bradner, J. E., Zuber, J., Shortt, J. & Johnstone, R. W. 28 Feb 2017 In : Cell Reports. 18, 9, p. 2162-2174 13 p.

Research output: Contribution to journalArticle

Open Access
File

Carfilzomib–dexamethasone versus subcutaneous or intravenous bortezomib in relapsed or refractory multiple myeloma: secondary analysis of the phase 3 ENDEAVOR study

Goldschmidt, H., Moreau, P., Ludwig, H., Niesvizky, R., Chng, W. J., Joshua, D., Weisel, K., Spencer, A., Orlowski, R. Z., Feng, S., Iskander, K. S. & Dimopoulos, M. A. 25 Sep 2017 (Accepted/In press) In : Leukemia and Lymphoma. p. 1-11 11 p.

Research output: Contribution to journalArticle

Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma

Mithraprabhu, S., Khong, T., Ramachandran, M., Chow, A., Klarica, D., Mai, L., Walsh, S., Broemeling, D., Marziali, A., Wiggin, M., Hocking, J., Kalff, A., Durie, B. & Spencer, A. 1 Aug 2017 In : Leukemia. 31, 8, p. 1695-1705 11 p.

Research output: Contribution to journalArticle

Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation

Yong, M. K., Cameron, P. U., Slavin, M., Morrissey, C. O., Bergin, K., Spencer, A., Ritchie, D., Cheng, A. C., Samri, A., Carcelain, G., Autran, B. & Lewin, S. R. 1 Jun 2017 In : Journal of Infectious Diseases. 215, 11, p. 1684-1694 11 p.

Research output: Contribution to journalArticle

Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma

Kumar, S. K., Moreau, P., Hari, P., Mateos, M-V., Ludwig, H., Shustik, C., Masszi, T., Spencer, A., Hájek, R., Romeril, K., Avivi, I., Liberati, A. M., Minnema, M. C., Einsele, H., Lonial, S., Berg, D., Lin, J., Gupta, N., Esseltine, D. L. & Richardson, P. G. 1 Aug 2017 In : British Journal of Haematology. 178, 4, p. 571-582 12 p.

Research output: Contribution to journalArticle

Pharmacokinetics and safety of carfilzomib in patients with relapsed multiple myeloma and end-stage renal disease (ESRD): an open-label, single-arm, phase I study

Quach, H., White, D. J., Spencer, A., Ho, P. J., Bhutani, D., White, M., Inamdar, S., Morris, C., Ou, Y. & Gyger, M. 1 Jun 2017 In : Cancer Chemotherapy and Pharmacology. 79, 6, p. 1067-1076 10 p.

Research output: Contribution to journalArticle

The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study

Tan, P., Tiong, I. S., Fleming, S., Pomilio, G., Cummings, N., Droogleever, M., McManus, J., Schwarer, A., Catalano, J., Patil, S., Avery, S., Spencer, A. & Wei, A. 2017 In : OncoTarget. 8, 32, p. 52269-52280 12 p.

Research output: Contribution to journalArticle

Open Access

Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group

Talaulikar, D. , Tam, C. S. , Joshua, D. E. , Ho, P. J. , Szer, J. , Quach, H. , Spencer, A. , Harrison, S. J. , Mollee, P. , Roberts, A. W. , Horvath, N. , Lee, C. , Zannettino, A. C. W. , Brown, R. D. , Augustson, B. M. , Jaksic, W. J. , Gibson, J. , Kalff, A. , Johnston, A. , Trotman, J. & 4 others Kalro, A., Grigoriadis, G., Ward, C. & Prince, H. M. 1 Jan 2017 In : Internal Medicine Journal. 47, 1, p. 35-49 15 p.

Research output: Contribution to journalArticle

2016

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): And randomised, phase 3, open-label, multicentre study

Dimopoulos, M. A. , Moreau, P. , Palumbo, A. , Joshua, D. E. , Pour, L. , Hájek, R. , Facon, T. , Ludwig, H. , Oriol, A. , Goldschmidt, H. , Rosiñol, L. , Straub, J. , Suvorov, A. , Araujo, C. , Rimashevskaya, E. , Pika, T. , Gaidano, G. , Weisel, K. C. , Goranova-Marinova, V. , Schwarer, A. & 11 others Minuk, L., Masszi, T., Karamanesht, I., Offidani, M., Hungria, V., Spencer, A., Orlowski, R. Z., Gillenwater, H. H., Mohamed, N., Feng, S. & Chng, W. J. 1 Jan 2016 In : Lancet Oncology. 17, 1, p. 27-38 12 p.

Research output: Contribution to journalArticle

Changes in bone turnover marker levels and clinical outcomes in patients with advanced cancer and bone metastases treated with bone antiresorptive agents

Lipton, A., Smith, M. R., Fizazi, K., Stopeck, A. T., Henry, D. A., Brown, J. E., Shore, N. D., Saad, F., Spencer, A., Zhu, L. & Warner, D. J. 1 Dec 2016 In : Clinical Cancer Research. 22, 23, p. 5713-5721 9 p.

Research output: Contribution to journalArticle

Open Access

Daratumumab, bortezomib, and dexamethasone for multiple myeloma

Palumbo, A., Chanan-Khan, A., Weisel, K. C., Nooka, A. K., Masszi, T., Beksac, M., Spicka, I., Hungria, V., Munder, M., Mateos, M-V., Mark, T. M., Qi, M., Schecter, J., Amin, H., Qin, X., Deraedt, W., Ahmadi, T., Spencer, A. & Sonneveld, P. 25 Aug 2016 In : New England Journal of Medicine. 375, 8, p. 754-766 13 p.

Research output: Contribution to journalArticle

Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry

Bergin, K., Moore, E., McQuilten, Z., Wood, E., Augustson, B., Blacklock, H., Ho, J., Horvath, N., King, T., McNeil, J., Mollee, P., Quach, H., Reid, C. M., Rosengarten, B., Walker, P. & Spencer, A. 9 Nov 2016 In : BMC Medical Research Methodology. 16, 1, 8 p., 151

Research output: Contribution to journalArticle

Open Access

Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial

Raje, N., Vadhan-Raj, S., Willenbacher, W., Terpos, E., Hungria, V., Spencer, A., Alexeeva, Y., Facon, T., Stewart, A. K., Feng, A., Braun, A., Balakumaran, A. & Roodman, G. D. 8 Jan 2016 In : Blood Cancer Journal. 6, e378

Research output: Contribution to journalArticle

Open Access
File

Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myeloma

Orlowski, R. Z., Nagler, A., Sonneveld, P., Bladé, J., Hajek, R., Spencer, A., Robak, T., Dmoszynska, A., Horvath, N., Spicka, I., Sutherland, H. J., Suvorov, A. N., Xiu, L., Cakana, A., Parekh, T. & San-Miguel, J. F. 1 Jul 2016 In : Cancer. 122, 13, p. 2050-2056 7 p.

Research output: Contribution to journalArticle

Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients

Levin, N., Spencer, A., Harrison, S. J., Chauhan, D., Burrows, F. J., Anderson, K. C., Reich, S. D., Richardson, P. G. & Trikha, M. 1 Sep 2016 In : British Journal of Haematology. 174, 5, p. 711-720 10 p.

Research output: Contribution to journalArticle

Open Access
File

Mitochondrial DNA plasticity is an essential inducer of tumorigenesis

Lee, W. T. Y., Cain, J. E., Cuddihy, A. R., Dickinson, A., Yeung, K-Y., Kumar, B., Johns, T. G., Watkins, D. N., Spencer, A., St John, J. C. & Johnson, J. 2016 In : Cell Death Discovery. 2, p. 1 - 11 11 p., 16016

Research output: Contribution to journalArticle

Open Access
File

Phase i clinical trial of marizomib (NPI-0052) in patients with advanced malignancies including multiple myeloma: Study NPI-0052-102 final results

Harrison, S. J., Mainwaring, P., Price, T., Millward, M. J., Padrik, P., Underhill, C. R., Cannell, P. K., Reich, S. D., Trikha, M. & Spencer, A. 15 Sep 2016 In : Clinical Cancer Research. 22, 18, p. 4559-4566 8 p.

Research output: Contribution to journalArticle

Open Access

Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: A multicentre audit

Doan, T. N., Kirkpatrick, C. M. J., Walker, P., Slavin, M. A., Ananda-Rajah, M. R., Morrissey, C. O., Urbancic, K. F., Grigg, A. P., Spencer, A., Szer, J., Seymour, J. F. & Kong, D. C. M. 1 Feb 2016 In : Journal of Antimicrobial Chemotherapy. 71, 2, p. 497-505 9 p., dkv343

Research output: Contribution to journalArticle

Open Access
File

Second Cancer Risk and Late Mortality in Adult Australians Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Population-Based Cohort Study

Vajdic, C. M. , Mayson, E. , Dodds, A. J. , O'Brien, T. , Wilcox, L. , Nivison-Smith, I. , Le Marsney, R. , Daniels, B. , Ashton, L. J. , Tan, J. , Bilmon, I. , Aarons, D. , Tran, S. , Gibson, J. , Johnston, A. , Greenwood, M. , Forbes, K. M. , Hertzberg, M. , Huang, J. G. , Spencer, A. & 28 others Muirhead, J. L., Szer, J., Mason, K., Lewis, I., To, C., Durrant, S., Western, R., Cannell, P., Buffery, S., Oswald, C., Nelson, A., Shaw, P., Pearson, L., Tiedemann, K., Scoyne, M., Fraser, C., Seljak, J., Cole, N. C., Rowland, K., Gough, K. H., Tapp, H., Green, N., Moa, A., McRae, J., Jenkins, M., Hicks, J., Chaplin, K. & CAST study investigators 1 May 2016 In : Biology of Blood and Marrow Transplantation. 22, 5, p. 949-956 8 p.

Research output: Contribution to journalArticle

2015

Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: A randomised, multicentre, phase 3 trial

Gay, F. , Oliva, S. , Petrucci, M. T. , Conticello, C. , Catalano, L. , Corradini, P. , Siniscalchi, A. , Magarotto, V. , Pour, L. , Carella, A-M. , Malfitano, A. , Petrò, D. , Evangelista, A. , Spada, S. , Pescosta, N. , Omedè, P. , Campbell, P. , Liberati, A. M. , Offidani, M. , Ria, R. & 6 others Pulini, S., Patriarca, F., Hajek, R., Spencer, A., Boccadoro, M. & Palumbo, A. 2015 In : Lancet Oncology. 16, 16, p. 1617-1629 13 p.

Research output: Contribution to journalArticle

Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantation

Pham, T., Patil, S., Fleming, S. A., Avery, S., Walker, P. A., Wei, A., Curtis, D. J., Stuart, G., Klarica, D., O'Brien, M., Morris, K., Das, T. P., Bollard, G. M., Muirhead, J., Coutsouvelis, J. & Spencer, A. 2015 In : Transfusion. 55, 11, p. 2709 - 2713 5 p.

Research output: Contribution to journalArticle

Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone

Dimopoulos, M. A. , Weisel, K. C. , Song, K. W. , Delforge, M. , Karlin, L. , Goldschmidt, H. , Moreau, P. , Banos, A. , Oriol, A. , Garderet, L. , Cavo, M. M. , Ivanova, V. , Alegre, A. , Martinez-Lopez, J. , Chen, C. , Spencer, A. , Knop, S. , Bahlis, N. J. , Renner, C. , Yu, X. & 5 others Hong, K., Sternas, L., Jacques, C., Zaki, M. & San Miguel, J. F. 2015 In : Haematologica: the hematology journal. 100, 10, p. 1327 - 1333 7 p.

Research output: Contribution to journalArticle

Open Access

Elotuzumab therapy for relapsed or refractory multiple myeloma

Lonial, S. , Dimopoulos, M. A. , Palumbo, A. , White, D. J. , Grosicki, S. , Spicka, I. , Walter-Croneck, A. , Moreau, P. , Mateos, M-V. , Magen, H. , Belch, A. R. , Reece, D. E. , Beksac, M. , Spencer, A. , Oakervee, H. , Orlowski, R. Z. , Taniwaki, M. , Rollig, C. , Einsele, H. , Wu, K. L. & 8 others Singhal, A., San Miguel, J. F., Matsumoto, M., Katz, J., Bleickardt, E., Poulart, V., Anderson, K. C. & Richardson, P. G. 2015 In : New England Journal of Medicine. 373, 7, p. 621 - 631 11 p.

Research output: Contribution to journalArticle

Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia

Wei, A., Tan, P. T. G., Perruzza, S. N., Govindaraj, C., Fleming, S. A., McManus, J. F., Avery, S., Patil, S., Stevenson, W. C., Plebanski, M. & Spencer, A. 2015 In : British Journal of Haematology. 169, 2, p. 199 - 210 12 p.

Research output: Contribution to journalArticle

MDX-1097 induces antibody-dependent cellular cytotoxicity against kappa multiple myeloma cells and its activity is augmented by lenalidomide

Asvadi, P., Cuddihy, A. R., Dunn, R., Jiang, V., Wong, M. X., Jones, D. R., Khong, T. T. F. & Spencer, A. 2015 In : British Journal of Haematology. 169, 3, p. 333 - 343 11 p.

Research output: Contribution to journalArticle

Modifying chemotherapeutic management of a patient with Burkitt's lymphoma and pre-existing motor neurone disease

Bortz, H. D., Coutsouvelis, J., Corallo, C., Spencer, A. & Patil, S. 2015 In : Journal of Clinical Pharmacy and Therapeutics. 40, 4, p. 483 - 485 3 p.

Research output: Contribution to journalArticle

Phase 1/1B trial of the heat shock protein 90 inhibitor NVP-AUY922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myeloma

Seggewiss-Bernhardt, R., Bargou, R. C., Goh, Y. T., Stewart, A. K., Spencer, A., Alegre, A., Blade, J., Ottman, O. G., Fernandez-Ibarra, C., Lu, H., Pain, S., Akimov, M. & Iyer, S. P. 2015 In : Cancer. 121, 13, p. 2185 - 2192 8 p.

Research output: Contribution to journalArticle

Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocation

Scheid, C., Reece, D. E., Beksac, M., Spencer, A., Callander, N. S., Sonneveld, P., Kalimi, G., Cai, C., Shi, M. M., Scott, J. W. & Stewart, A. K. 2015 In : European Journal of Haematology. 95, 4, p. 316 - 324 9 p.

Research output: Contribution to journalArticle

Revised international staging system for multiple myeloma: a report from international myeloma working group

Palumbo, A. , Avet-Loiseau, H. , Olivia, S. , Lokhorst, H. M. , Goldschmidt, H. , Rosinol, L. , Richardson, P. G. , Caltagirone, S. , Lahuerta, J. J. , Facon, T. , Bringhen, S. , Gay, F. , Attal, M. , Passera, R. , Spencer, A. , Offidani, M. , Kumar, S. K. , Musto, P. , Lonial, S. , Petrucci, M. T. & 11 others Orlowski, R. Z., Zamagni, E., Morgan, G., Dimopoulos, M. A., Durie, B. G. M., Anderson, K. C., Sonneveld, P., San Miguel, J. F., Cavo, M. M., Rajkumar, S. V. & Moreau, P. 2015 In : Journal of Clinical Oncology. 33, 26, p. 2863 - 2869 7 p.

Research output: Contribution to journalArticle

The addition of dexamethasone to bortezomib for patients with relapsed multiple myeloma improves outcome but ongoing maintenance therapy has minimal benefit

Harrison, S. J. A., Quach, H., Link, E. K., Feng, H., Dean, J., Copeman, M. B., van de Velde, H., Schwarer, A., Baker, B., Spencer, A., Catalano, J., Campbell, P., Augustson, B. M., Romeril, K. & Prince, H. M. 2015 In : American Journal of Hematology. 90, 5, p. 86 - 91 6 p.

Research output: Contribution to journalArticle

The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease

Diel, I. J., Body, J-J., Stopeck, A. T., Vadhan-Raj, S., Spencer, A., Steger, G., von Moos, R., Goldwasser, F., Feng, A. & Braun, A. H. 2015 In : European Journal of Cancer. 51, 11, p. 1467 - 1475 9 p.

Research output: Contribution to journalArticle

Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: Position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group

Quach, H., Joshua, D., Ho, J., Szer, J., Spencer, A., Harrison, S. J., Mollee, P., Roberts, A. W., Horvath, N., Talulikar, D., To, B., Zannettino, A. C. W., Brown, R., Catley, L. P., Augustson, B. M., Jaksic, W. J., Gibson, J. & Prince, H. M. 1 Jan 2015 In : Internal Medicine Journal. 45, 1, p. 94-105 12 p.

Research output: Contribution to journalArticle

Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: Position statement of the myeloma foundation of Australia Medical and Scientific Advisory Group (

Quach, H., Joshua, D. E., Ho, J., Szer, J., Spencer, A., Harrison, S., Mollee, P. N., Roberts, A. W., Horvath, N., Talaulikar, D., To, B., Zannettino, A. C. W., Brown, R. D., Catley, L. P., Augustson, B. M., Jaksic, W. J., Gibson, J. L. & Prince, H. M. 2015 In : Internal Medicine Journal. 45, 3, p. 335-343 9 p.

Research output: Contribution to journalArticle

2014

Comparison of the probability of target attainment of anidulafungin against Candida spp. in patients with acute leukaemia

Doan, T. N., Kong, D. C. M., Patel, K., Walker, P. A., Spencer, A. & Kirkpatrick, C. M. J. 2014 In : International Journal of Antimicrobial Agents. 44, 5, p. 450 - 457 8 p.

Research output: Contribution to journalArticle

Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome

Tan, P., Wei, A., Mithraprabhu, S., Cummings, N. J., Liu, H. B., Perugini, M., Reed, K. D., Avery, S., Patil, S., Walker, P. A., Mollee, P. N., Grigg, A. P., D'Andrea, R. J., Dear, A. E. & Spencer, A. 2014 In : Blood Cancer Journal. 4, 1, p. 1 - 8 8 p., e170

Research output: Contribution to journalArticle

Open Access

Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma

Mithraprabhu, S., Kalff, A., Chow, A., Khong, T. T. F. & Spencer, A. 2014 In : Epigenetics. 9, 11, p. 1511 - 1520 10 p.

Research output: Contribution to journalArticle

Fludarabine Melphalan reduced-intensity conditioning allotransplanation provides similar disease control in lymphoid and myeloid malignancies: Analysis of 344 patients

Bryant, R. A., Nivison-Smith, I., Pillai, E. S., Kennedy, G., Kalff, A., Ritchie, P. D., George, B., Hertzberg, M., Patil, S., Spencer, A., Fay, K., Cannell, P., Berkahn, L., Doocey, R., Spearing, R. & Moore, J. 2014 In : Bone Marrow Transplantation. 49, 1, p. 17-23 7 p.

Research output: Contribution to journalArticle

International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation

Palumbo, A. , Rajkumar, S. V. , San Miguel, J. F. , Larocca, A. T. , Niesvizky, R. , Morgan, G. , Landgren, O. , Hajek, R. , Einsele, H. , Anderson, K. C. , Dimopoulos, M. A. , Richardson, P. G. , Cavo, M. M. , Spencer, A. , Stewart, A. K. , Shimizu, K. , Lonial, S. , Sonneveld, P. , Durie, B. G. M. , Moreau, P. & 1 others Orlowski, R. Z. 2014 In : Journal of Clinical Oncology. 32, 6, p. 587 - 600 14 p.

Research output: Contribution to journalArticle

Mechanisms and potential molecular markers of early response to combination epigenetic therapy in patients with myeloid malignancies

Liu, H. B., Urbanavicius, D. B., Tan, P., Spencer, A. & Dear, A. E. 2014 In : International Journal of Oncology. 45, 4, p. 1742 - 1748 7 p.

Research output: Contribution to journalArticle

Open Access

Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma

San Miguel, J. F. , Blade, J. , Shpilberg, O. , Grosicki, S. , Maloisel, F. , Min, C-K. , Zarzuela, M. P. , Robak, T. , Prasad, S. V. S. S. , Goh, Y. T. , Laubach, J. P. , Spencer, A. , Mateos, M. V. , Palumbo, A. , Puchalski, T. A. , Reddy, M. P. , Uhlar, C. M. , Qin, X. , van de Velde, H. , Xie, H. & 1 others Orlowski, R. Z. 2014 In : Blood. 123, 26, p. 4136 - 4142 7 p.

Research output: Contribution to journalArticle

Open Access

Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: A population-based cohort study

Bilmon, I. A. , Ashton, L. J. , Le Marsney, R. E. , Dodds, A. J. , O'Brien, T. , Wilcox, L. , Nivison-Smith, I. , Daniels, B. , Vajdic, C. M. , Ashton, L. J. , Le Marsney, R. , Dodds, A. , Tan, J. , Bilmon, I. , Wilcox, L. , Nivison-Smith, I. , Aarons, D. , Tran, S. , Gibson, J. , Johnston, A. & 33 others Greenwood, M., Forbes, K. M., Hertzberg, M., Huang, J. G., Spencer, A., Muirhead, J. L., Szer, J., Mason, K., Lewis, I., To, C., Durrant, S., Western, R., Cannell, P., Buffery, S., O'Brien, T., Oswald, C., Nelson, A., Shaw, P., Pearson, L., Tiedemann, K., Scoyne, M., Fraser, C., Seljak, J., Cole, N. C., Rowland, K., Gough, K. H., Tapp, H., Green, N., Moa, A., McRae, J., Jenkins, M., Hicks, J. & Chaplin, K. 1 May 2014 In : Bone Marrow Transplantation. 49, 5, p. 691-698 8 p.

Research output: Contribution to journalArticle

Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data

Palumbo, A. , Bringhen, S. , Kumar, S. K. , Lupparelli, G. , Usmani, S. Z. , Waage, A. , Larocca, A. T. , Van Der Holt, B. R. , Musto, P. , Offidani, M. , Petrucci, M. T. , Evangelista, A. , Zweegman, S. , Nooka, A. K. , Spencer, A. , Dimopoulos, M. A. , Hajek, R. , Cavo, M. M. , Richardson, P. G. , Lonial, S. & 6 others Ciccone, G., Boccadoro, M., Anderson, K. C., Barlogie, B. M., Sonneveld, P. & McCarthy, P. L. 2014 In : Lancet Oncology. 15, 3, p. 333 - 342 10 p.

Research output: Contribution to journalArticle

Thalidomide and prednisolone versus prednisolone alone as consolidation therapy after autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: Final analysis of the ALLG MM6 multicentre, open-label, randomised phase 3 study

Kalff, A., Kennedy, N., Smiley, A., Miles Prince, H., Roberts, A. W., Bradstock, K., de Abreu Lourenço, R., Frampton, C. & Spencer, A. 2014 In : The Lancet Haematology. 1, 3, p. e112-e119 8 p.

Research output: Contribution to journalArticle

The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma

Spencer, A., Yoon, S-S., Harrison, S., Morris, S. R., Smith, D. A., Brigandi, R. A., Gauvin, J. L. S., Kumar, R., Opalinska, J. B. & Chen, C. 2014 In : Blood. 124, 14, p. 2190 - 2195 6 p.

Research output: Contribution to journalArticle